Table 1.
Phytochemical analysis of crude extract of I. albicans.
Table 2.
Antibacterial activity of I. albicans crude and corresponding fractions.
Fig 1.
Zone of inhibition of extract against specific bacteria.
Aqua: Aqueous Sub-fraction: C.F: Chloroform Sub-fraction; DMSO: Dimethyl Sulfoxide Sub-fraction; E.A: Ethyl Acetate Sub-fraction; L.F: Levofloxacin; M.E: Methanolic Extract; MERO: Meropenam.
Fig 2.
Inhibition of bacterial growth by extract.
Aqua: Aqueous Sub-fraction: C.F: Chloroform Sub-fraction; DMSO: Dimethyl Sulfoxide Sub-fraction; E.A: Ethyl Acetate Sub-fraction; L.F: Levofloxacin; M.E: Methanolic Extract; MERO: Meropenam.
Table 3.
Antifungal activity of I. albicans crude and corresponding fractions.
Fig 3.
Comparison of antifungal activity of Iris albicans crude extract and its corresponding fractions.
Table 4.
Effect of IACCF on acetic acid-induced abdominal constriction in mice.
Table 5.
Effect of Iris albicans crude and its corresponding fractions on hot-plate test in mice.
Fig 4.
Analgesic activity of Iris albicans crude extract and its sub-fractions.
Analgesic effect was evaluated using Hot -Plate test in animal model (n = 6).
Table 6.
Effect of Iris albicans crude and its corresponding fractions on tail-immersion test in mice.